Telomir Pharmaceuticals (TELO) Change in Cash (2023 - 2025)
Telomir Pharmaceuticals (TELO) posted Change in Cash of -$42628.0 for Q4 2025, down 100.65% sequentially from $6.6 million in Q3 2025, and down 109.88% YoY from $431493.0 in Q4 2024.
Telomir Pharmaceuticals (TELO) Change in Cash (2023 - 2025) Analysis & Trends
Telomir Pharmaceuticals has reported Change in Cash for 3 years, with the latest figure at -$42628.0 in Q4 2025.
- Quarterly Change in Cash fell 109.88% year-over-year to -$42628.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.0 million (up 375.97% YoY) and the FY2025 annual result came in at $6.0 million, up 375.97% from the prior year.
- Change in Cash retreated to -$42628.0 in Q4 2025 per TELO's latest filing, from $6.6 million in the prior quarter.
- Over five years, Change in Cash peaked at $6.6 million in Q3 2025 and troughed at -$1.4 million in Q2 2024.
- A 3-year average of $607104.2 and a median of -$416.5 in 2023 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 843478.09% in 2024, down 10943.9% in 2024.
- Over 3 years, Change in Cash stood at -$1221.0 in 2023, then jumped by 35439.31% to $431493.0 in 2024, then slumped by 109.88% to -$42628.0 in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered -$42628.0, $6.6 million, and $351324.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Telomir Pharmaceuticals | 69.05 Mn | 69.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42,628.00 |
| Sep 30, 2025 | 6.57 Mn |
| Jun 30, 2025 | 351,324.00 |
| Mar 31, 2025 | -863,132.00 |
| Dec 31, 2024 | 431,493.00 |
| Sep 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | -1,221.00 |
| Sep 30, 2023 | -12,177.00 |
| Jun 30, 2023 | 12,822.00 |
| Mar 31, 2023 | 388.00 |